Preliminary study on the mechanism of abnormal energy metabolism in patients with liver failure and the influence of metabolic status, cytokines and T3 levels on the prognosis of patients

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100043064

Enrollment

Unknown

Registered

2021-02-04

Start date

2021-02-01

Completion date

Unknown

Last updated

2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Failure

Interventions

The nonsurvival group:Comprehensive medical treatment

The survival group :Comprehensive medical treatment

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18-70 years; 2.The diagnosis of liver failure complies with the "Guidelines for Diagnosis and Treatment of Liver Failure 2018".

Exclusion criteria

Exclusion criteria: 1. Patients with liver cancer or other malignant tumors; 2. Patients with thyroid diseases such as hyperthyroidism or hypothyroidism; 3. Patients with diabetes mellitus; 4. People with serious underlying diseases, including heart, brain, lung, kidney, digestion, blood, neuropsychiatric and other diseases; 5. Patients co-infected with human immunodeficiency virus; 6. Combined with underlying diseases that require anticoagulant drugs; 7. Pregnant women and lactating patients; 8. Poor compliance.

Design outcomes

Primary

Measure	Time frame
Assessment of disease severity and malnutrition;Detection of energy metabolism and human body composition;Laboratory indicators;	—

Countries

China

Contacts

Public ContactXing Liu

Linyi People's Hospital

lxgjl@163.com+86 13562987695

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026